Synonyms: Bexxar® | V10XA53
tositumomab is an approved drug (FDA (2003))
Compound class:
Antibody
Comment: Tositumomab was used as a radioimmunotherapy drug, targeting CD20 on B-lymphocytes prior to cessation of its manufacture.
|
Classification | |
Compound class | Antibody |
Approved drug? | Yes (FDA (2003)) |
Withdrawn drug? | Yes |
International Nonproprietary Names | |
INN number | INN |
7827 | tositumomab |
Synonyms |
Bexxar® | V10XA53 |
Database Links | |
Specialist databases | |
IMGT/mAb-DB | 142 |
Other databases | |
GtoPdb PubChem SID | 178103387 |
PubChem SID | 178103387 |
Search PubMed clinical trials | tositumomab |
Search PubMed titles | tositumomab |
Search PubMed titles/abstracts | tositumomab |
Wikipedia | Tositumomab |